Androgen-induced cell growth and c-myc expression in human non-transformed epithelial prostatic cells in primary culture

Endocrine Research

Volumn 27, Issue 1-2, 2001, Pages 153-169

  Silva, I S B ^a   Morsch, D M ^a   Urnauer, L ^a   Spritzer, P M ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; BETA 2 MICROGLOBULIN; COMPLEMENTARY DNA; HYDROXYFLUTAMIDE; MESSENGER RNA; RNA; TESTOSTERONE;

ADULT; AGED; ARTICLE; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HORMONE ACTION; HUMAN; HUMAN CELL; MALE; NORTHERN BLOTTING; ONCOGENE C MYC; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE HYPERTROPHY; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; ANDROGENS; BLOTTING, NORTHERN; CELL DIVISION; DIHYDROTESTOSTERONE; EPITHELIAL CELLS; FLUTAMIDE; GENE EXPRESSION; HUMANS; KINETICS; MALE; MIDDLE AGED; PROSTATE; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TESTOSTERONE;

EID: 0034976039     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.1081/ERC-100107177     Document Type: Article

References (41)

1. Benign prostatic hyperplasia: A review of its histogenesis and natural history
2. A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia
3. Steroid hormone regulation of nuclear proto-oncogenes
4. 1 transition in nontransformed cells
5. Cell-specific regulation of the c-myc gene by lymphocyte antigens and platelet-derived growth factor
6. The myc oncogene: Its role in transformation and differentiation
7. The oncogenes
8. Effects of sex steroids on cell growth and c-myc oncogenes expression in LNCaP and DU145 prostatic carcinoma cell lines
9. Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia
10. Differential gene regulation during programmed death (Apoptosis) versus proliferation of prostatic glandular cells induced by androgen manipulation
11. Androgens are not a direct requirement for the proliferation of human prostatic epithelium In vitro
12. Serum-free growth of adult human prostatic epithelial cells
13. Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells
14. Coregulatory effects of epidermal growth factor, dihydrotestosterone, and prolactin on benign human prostatic hyperplasia tissue culture proliferation
15. Extended culturing of androgen-responsive human primary epithelial prostate cell isolates by continuous treatment with interstitial collagenase
16. Negative controls of cell proliferation: Human prostate cancer cells and androgens
17. Characteristics of the biphasic action of androgens and of the potent anti-proliferative effects of the new pure antiestrogen EM-139 on cell cycle kinetic parameters in LNCaP human prostatic cancer cells
18. Establishment and characterization of an immortalized but nontransformed human prostate epithelial cell line: BPH-1
19. Estradiol stimulates c-myc proto-oncogene expression in normal human breast epithelial cells in culture
20. Culture of adult human prostatic epithelial cells: A simplified method for obtaining primary cultures
21. A study of the mechanism of the diphenylamine reaction for the colorimetric estimation of DNA
22. Effects of tamoxifen on prolactin levels, pituitary immunoreactive prolactin cells and uterine growth in estradiol-treated ovariectomized rats
23. Progestin modulation of c-fos and prolactin gene expression in the human endometrium
24. Monitoring mRNA expression by polymerase chain reaction: The "Primer-dropping" method
25. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer
26. A biological profile of a nonsteroidal antiandrogen, SCH 13521 (4′-nitro-3′-tri-fluoromethyl-isobutyranilide)
27. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues
28. Growth factors as mediators of androgen action during male urogenital development
29. Hormonal signaling in prostatic hyperplasia and neoplasia
30. Androgen and oestrogen responsiveness of stromal cells derived from the human hyperplastic Prostate: Oestrogen regulation of the androgen receptor
31. Effect of finasteride (Proscar) on the proliferation of cultured epithelial and stromal cells from normal and hyperplastic human prostates
32. The proliferative effect of "Anti-androgens" on the androgen-sensitive human prostate tumor cell line LNCaP
33. Effects of DHT and EGF on human hyperplastic prostate cells cultured In vitro: Growth, morphology and phenotype characterisation
34. Hormonal regulation of the androgen receptor expression in human prostatic cells in culture
35. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model
36. Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells LNCaP, by dihydrotestosterone
37. The role of transforming growth factor-b1, b2, and b3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells
38. Expression of novel genes linked to the androgen-induced, proliferative shutoff in prostate cancer cells
39. In situ expression of mRNA for proto-oncogenes in benign prostatic hyperplasia and in prostatic carcinoma
40. Regulation of prostate growth
41. Nuclear protooncogenes as regulatory genes and as marker genes for steroid action in all target tissues